| Year |
Citation |
Score |
| 2014 |
Gulyás B, Sovago J, Gomez-Mancilla B, Jia Z, Szigeti C, Gulya K, Schumacher M, Maguire RP, Gasparini F, Halldin C. Decrease of mGluR5 receptor density goes parallel with changes in enkephalin and substance P immunoreactivity in Huntington's disease: a preliminary investigation in the postmortem human brain. Brain Structure & Function. PMID 24969128 DOI: 10.1007/S00429-014-0812-Y |
0.466 |
|
| 2006 |
Sovago J, Farde L, Cervenka S, Halldin C, Gulyas B. Increasing the accuracy of in vivo quantification of dopamine-D2/D3 receptor binding in the human brain by partial volume effect correction Neuroimage. 31: T85. DOI: 10.1016/J.Neuroimage.2006.04.073 |
0.62 |
|
| 2006 |
Schou M, Pike V, Sóvágó J, Gulyás B, Gallagher P, Dobson D, Walter M, Rudyk H, Farde L, Halldin C. Synthesis of 11C-labeled (S,S)-CFMME and (R)-OHDMI and their evaluation as candidate radioligands for imaging norepinephrine transporters with PET Neuroimage. 31: T48. DOI: 10.1016/j.neuroimage.2006.04.039 |
0.51 |
|
| 2005 |
Seneca N, Andree B, Sjoholm N, Schou M, Pauli S, Mozley PD, Stubbs JB, Liow JS, Sovago J, Gulyás B, Innis R, Halldin C. Whole-body biodistribution, radiation dosimetry estimates for the PET norepinephrine transporter probe (S,S)-[18F]FMeNER-D2 in non-human primates. Nuclear Medicine Communications. 26: 695-700. PMID 16000987 DOI: 10.1097/01.Mnm.0000171780.72908.E7 |
0.518 |
|
| 2004 |
McCarron JA, Pike VW, Halldin C, Sandell J, Sóvágó J, Gulyas B, Cselényi Z, Wikström HV, Marchais-Oberwinkler S, Nowicki B, Dollé F, Farde L. The pyridinyl-6 position of WAY-100635 as a site for radiofluorination--effect on 5-HT1A receptor radioligand behavior in vivo. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 6: 17-26. PMID 15018825 DOI: 10.1016/J.Mibio.2003.12.001 |
0.689 |
|
| 2002 |
Vas A, Sóvágó J, Halldin C, Sandell J, Karlsson P, Kárpáti E, Kiss B, Cselényi Z, Farde L, Gulyás B. [Cerebral uptake and regional distribution of [11C]-vinpocetin after intravenous administration to healthy men: a PET study]. Orvosi Hetilap. 143: 2631-6. PMID 12532649 |
0.727 |
|
| 2002 |
Gulyás B, Halldin C, Sandell J, Karlsson P, Sóvágó J, Kárpáti E, Kiss B, Vas A, Cselényi Z, Farde L. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects. Acta Neurologica Scandinavica. 106: 325-32. PMID 12460136 DOI: 10.1034/J.1600-0404.2002.01302.X |
0.72 |
|
| 2002 |
Gulyás B, Vas A, Halldin C, Sóvágó J, Sandell J, Olsson H, Fredriksson A, Stone-Elander S, Farde L. Cerebral uptake of [ethyl-11C]vinpocetine and 1-[11C]ethanol in cynomolgous monkeys: a comparative preclinical PET study. Nuclear Medicine and Biology. 29: 753-9. PMID 12381455 DOI: 10.1016/S0969-8051(02)00319-0 |
0.552 |
|
| 2002 |
Sandell J, Halldin C, Sovago J, Chou YH, Gulyás B, Yu M, Emond P, Någren K, Guilloteau D, Farde L. PET examination of [(11)C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporter. Nuclear Medicine and Biology. 29: 651-6. PMID 12234589 DOI: 10.1016/S0969-8051(02)00318-9 |
0.635 |
|
| 2002 |
Gulyás B, Halldin C, Sóvágó J, Sandell J, Cselényi Z, Vas A, Kiss B, Kárpáti E, Farde L. Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine. European Journal of Nuclear Medicine and Molecular Imaging. 29: 1031-8. PMID 12173017 DOI: 10.1007/S00259-002-0823-4 |
0.701 |
|
| 2001 |
Gulyás B, Halldin C, Sóvágó J, Sandell J, Cselényi Z, Karlsson P, Kárpáti E, Kiss B, Vas A, Farde L. A novel principle of radiotracer administration in human brain mapping: pet studies on brain uptake and distribution of orally and intravenously administered [11C]vinpocetine Neuroimage. 13: 12. DOI: 10.1016/S1053-8119(01)91355-2 |
0.644 |
|
| 2001 |
Sandell J, Yu M, Emond P, Gulyas B, Cselenyi Z, Sovago J, Garreau L, Hall H, Chalon S, Guilloteau D, Någren K, Farde L, Halldin C. Radiolabeling, preliminary biological evaluation and pet examination in monkey of 5-methyl-6-nitroquipazine - a potential serotonin transporter radioligand Journal of Labelled Compounds and Radiopharmaceuticals. 44: S170-S172. DOI: 10.1002/JLCR.2580440159 |
0.647 |
|
| 2001 |
Sandell J, Mccarron JA, Halldin C, Pike VW, Gulyas B, Cselenyi Z, Sovago J, Marchais S, Wikström HV, Farde L. [18F]6FPWAY - a prospective 5-HT1A receptor radioligand - radiolabeling and pet examination in monkey - comparison with [11C]6FPWAY Journal of Labelled Compounds and Radiopharmaceuticals. 44: S167-S169. DOI: 10.1002/Jlcr.2580440158 |
0.671 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
DeLorenzo C, Sovago J, Gardus J, Xu J, Yang J, Behrje R, Kumar JS, Devanand DP, Pelton GH, Mathis CA, Mason NS, Gomez-Mancilla B, Aizenstein H, Mann JJ, Parsey RV. Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [(11)C]ABP688. Translational Psychiatry. 5: e693. PMID 26645628 DOI: 10.1038/Tp.2015.189 |
0.279 |
|
| 2013 |
Akkus F, Ametamey SM, Treyer V, Burger C, Johayem A, Umbricht D, Gomez Mancilla B, Sovago J, Buck A, Hasler G. Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography. Proceedings of the National Academy of Sciences of the United States of America. 110: 737-42. PMID 23248277 DOI: 10.1073/Pnas.1210984110 |
0.243 |
|
| 2014 |
Akkus F, Terbeck S, Ametamey SM, Rufer M, Treyer V, Burger C, Johayem A, Mancilla BG, Sovago J, Buck A, Hasler G. Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1915-22. PMID 24833114 DOI: 10.1017/S1461145714000716 |
0.223 |
|
| 2011 |
Deschwanden A, Karolewicz B, Feyissa AM, Treyer V, Ametamey SM, Johayem A, Burger C, Auberson YP, Sovago J, Stockmeier CA, Buck A, Hasler G. Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study. The American Journal of Psychiatry. 168: 727-34. PMID 21498461 DOI: 10.1176/Appi.Ajp.2011.09111607 |
0.197 |
|
| 2013 |
Hefti K, Holst SC, Sovago J, Bachmann V, Buck A, Ametamey SM, Scheidegger M, Berthold T, Gomez-Mancilla B, Seifritz E, Landolt HP. Increased metabotropic glutamate receptor subtype 5 availability in human brain after one night without sleep. Biological Psychiatry. 73: 161-8. PMID 22959709 DOI: 10.1016/J.Biopsych.2012.07.030 |
0.185 |
|
| 2015 |
Akkus F, Treyer V, Johayem A, Ametamey SM, Mancilla BG, Sovago J, Buck A, Hasler G. Association of Long-Term Nicotine Abstinence with Normal Metabotropic Glutamate Receptor-5 Binding. Biological Psychiatry. PMID 25861697 DOI: 10.1016/J.Biopsych.2015.02.027 |
0.118 |
|
| 2016 |
Trenkwalder C, Berg D, Rascol O, Eggert K, Ceballos-Baumann A, Corvol JC, Storch A, Zhang L, Azulay JP, Broussolle E, Defebvre L, Geny C, Gostkowski M, Stocchi F, Tranchant C, et al. A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26990766 DOI: 10.1002/mds.26569 |
0.103 |
|
| 2005 |
Erixon-Lindroth N, Farde L, Wahlin TB, Sovago J, Halldin C, Bäckman L. The role of the striatal dopamine transporter in cognitive aging. Psychiatry Research. 138: 1-12. PMID 15708296 DOI: 10.1016/J.Pscychresns.2004.09.005 |
0.076 |
|
| 1996 |
Sóvágó J, Newton MG, Mushina EA, Ungváry F. Intermediate complexes in the octacarbonyl dicobalt-initiated living polymerization of 3-methyl-1,2-butadiene Journal of the American Chemical Society. 118: 9589-9596. DOI: 10.1021/ja9542404 |
0.055 |
|
| 2015 |
Farlow MR, Andreasen N, Riviere ME, Vostiar I, Vitaliti A, Sovago J, Caputo A, Winblad B, Graf A. Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer's disease. Alzheimer's Research & Therapy. 7: 23. PMID 25918556 DOI: 10.1186/S13195-015-0108-3 |
0.049 |
|
| 2017 |
Vandenberghe R, Riviere ME, Caputo A, Sovago J, Maguire RP, Farlow M, Marotta G, Sanchez-Valle R, Scheltens P, Ryan JM, Graf A. Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study. Alzheimer's & Dementia (New York, N. Y.). 3: 10-22. PMID 29067316 DOI: 10.1016/J.Trci.2016.12.003 |
0.048 |
|
| 1994 |
Sóvágó J, Sisak A, Ungváry F, Markó L. Kinetics and mechanism of the methanolysis of acetylcobalt tetracarbonyl Inorganica Chimica Acta. 227: 297-300. DOI: 10.1016/0020-1693(94)04211-X |
0.045 |
|
| 1999 |
Szalontai G, Sóvágó J, Ungváry F. Solution- and solid-state NMR study of intermediate η3-allyl-cobalt tricarbonyl type complexes in 3-methyl-1,2-butadiene polymerization Journal of Organometallic Chemistry. 586: 54-60. |
0.043 |
|
| 2016 |
Crutcher E, Ali M, Harrison J, Sovago J, Gomez-Mancilla B, Schaaf CP. Assessment of Cognitive Outcome Measures in Teenagers with 15q13.3 Microdeletion Syndrome. Journal of Autism and Developmental Disorders. PMID 26754479 DOI: 10.1007/s10803-015-2694-0 |
0.031 |
|
| Hide low-probability matches. |